Using Iron With Procrit in Advanced Lung Cancer Patients With Chemotherapy-Induced Anemia
Status:
Withdrawn
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find a better, more convenient way to improve anemia results
by increasing the amount of medication given at 3 week intervals. Researchers want to know if
giving a higher dose of Procrit® and intravenous (IV) iron once every 3 weeks would give
better results in treating anemia without the need for more office visits.
Phase:
Phase 2
Details
Lead Sponsor:
James Graham Brown Cancer Center University of Louisville
Collaborators:
James Graham Brown Cancer Center University of Louisville